Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tie2, also known as TEK tyrosine kinase, is a receptor tyrosine kinase predominantly expressed in endothelial cells. It plays a critical role in the development, remodeling, and maintenance of blood and lymphatic vessels. Tie2 is essential for angiogenesis and vascular homeostasis. Its activity is tightly regulated by its ligands, the angiopoietins. Upon activation, Tie2 triggers several key pathways involved in cell survival, migration, proliferation, and vessel stability. Dysregulation or mutation of Tie2 has been implicated in pathological conditions such as tumor growth/metastasis, congenital glaucoma, lymphatic malformations, inflammation, and other vascular disorders.
Ligand-induced dimerization and autophosphorylation, leading to activation of downstream signaling pathways (PI3K/Akt, RAS/MAPK).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosine kinase with immunoglobulin-like and EGF-like domains (Tie2).